Mabwell Announces Transition to Electronic Delivery of Corporate Communications

Bulletin Express05-06

On 6 May 2026 Mabwell (Shanghai) Bioscience Co., Ltd. announced that all future corporate communications—including annual and interim reports, circulars, meeting notices and proxy forms—will be disseminated exclusively through the company’s website (www.mabwell.com) and the HKEX news portal (www.hkexnews.hk) in accordance with Rule 2.07A of the Hong Kong Stock Exchange Listing Rules. Printed copies will be supplied only upon request.

Non-registered shareholders preferring hard-copy documents must submit a completed request form to Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, or email 2493-ecom@vistra.com. Each request remains effective until the final day of Mabwell’s next financial year unless earlier revoked or superseded.

Mabwell will not issue separate notices each time a new document is uploaded; shareholders are expected to monitor the company’s and HKEX’s websites for updates. Enquiries can be directed to Tricor’s hotline on (852) 2980 1333 during business hours or by email to 2493-ecom@vistra.com.

The initiative, authorised by the board and signed by Chairman and Executive Director Dr. Liu Datao, aligns the biopharmaceutical company with HKEX’s ongoing push for paperless investor communications, aiming to enhance efficiency and reduce environmental impact.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment